This site is intended for healthcare professionals
News

Real-world study of Gilotrif shows second line treatment efficacy in squamous cell carcinoma of the lung.- Boehringer

Read time: 1 mins
Last updated:15th Oct 2020
Published:15th Oct 2020
Condition: Squamous Cell Carcinoma(Lung)
Type: drug
Register free for full access to medthority.com